ProPhase Labs (NASDAQ:PRPH) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of ProPhase Labs (NASDAQ:PRPHFree Report) in a research report sent to investors on Tuesday. The brokerage issued a sell rating on the stock.

ProPhase Labs Trading Up 5.5 %

Shares of PRPH stock opened at $0.46 on Tuesday. The stock has a 50 day simple moving average of $0.52 and a 200 day simple moving average of $1.42. The stock has a market cap of $11.09 million, a P/E ratio of -0.37 and a beta of -0.37. The company has a current ratio of 1.47, a quick ratio of 1.33 and a debt-to-equity ratio of 0.48. ProPhase Labs has a 1 year low of $0.22 and a 1 year high of $7.48.

Hedge Funds Weigh In On ProPhase Labs

Institutional investors have recently added to or reduced their stakes in the stock. SVB Wealth LLC bought a new position in ProPhase Labs in the fourth quarter valued at about $36,000. Squarepoint Ops LLC bought a new position in ProPhase Labs in the 4th quarter valued at approximately $40,000. Warberg Asset Management LLC acquired a new stake in ProPhase Labs during the 4th quarter worth approximately $77,000. Perritt Capital Management Inc grew its holdings in ProPhase Labs by 129.1% during the 4th quarter. Perritt Capital Management Inc now owns 190,000 shares of the company’s stock worth $144,000 after acquiring an additional 107,068 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in ProPhase Labs by 26.6% during the 4th quarter. Geode Capital Management LLC now owns 203,528 shares of the company’s stock worth $154,000 after acquiring an additional 42,793 shares during the last quarter. 9.45% of the stock is currently owned by institutional investors and hedge funds.

ProPhase Labs Company Profile

(Get Free Report)

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.

Read More

Receive News & Ratings for ProPhase Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProPhase Labs and related companies with MarketBeat.com's FREE daily email newsletter.